Skip to main content
. 2016 Jul 15;15(17):2256–2262. doi: 10.1080/15384101.2016.1208872

Figure 3.

Figure 3.

Comparison of multiple markers vs. single proliferation marker to adjust for the impact of cell proliferation. Kaplan-Meier plots of breast cancer specific survival for patients of the METABRIC cohort having primary tumors with high (above median) or low (under median) ORC6 transcript levels before (left) and after adjustment of its expression with Ki67 (middle) or the proliferation metagene (right). Hazard ratio (HR) between highest and lowest survival groups and p-value of the Log-rank (Mantel-Cox) test are displayed on the plots.